Guiar la identificación de mercado potencial, co-creación de propuestas técnicas comerciales para el desarrollo de nuevas aplicaciones para gases industriales y/o medicinales, basado en las metas compartidas de crecimiento de nuevos negocios. Aporta sólido conocimiento técnico, siendo capaz de acompañar y co-crear soluciones técnicas para clientes, en línea con los productos ofertados por el Grupo AL en su segmento.
Principales Funciones y/o Responsabilidades:
1- Desarrollo: Obtener informaciones técnicas en el área de desarrollo de productos y aplicaciones del grupo.
2- Clientes: atraer, cultivar, rentabilizar y establecer relaciones contractuales duraderas con los mismos.
3- Experiencia del cliente: Brindar excelente experiencia del cliente.
4- Cobros: acompañar y promover el cumplimiento en tiempo de los pagos de sus clientes.
5- Mercado: conocer las dinámicas y tendencias del mercado en torno a las aplicaciones (clientes, industria, país) y anticipar cambios.
6- Tecnología: Análisis e Implementación de nuevas tecnologías/soluciones en AL. Promover el uso de la tecnología que el grupo pone a nuestra disposición para el desarrollo de nuevos negocios y demostraciones en clientes.
7- Capacitar: Formación a Representantes Comerciales en aplicaciones.
At Air Liquide, we are committed to build a diverse and inclusive workplace that embraces the diversity of our employees, our customers, patients, community stakeholders and cultures across the world.
We welcome and consider applications from all qualified applicants, regardless of their background. We strongly believe a diverse organization opens up opportunities for people to express their talent, both individually and collectively and it helps foster our ability to innovate by living our fundamentals, acting for our success and creating an engaging environment in a changing world.
Air Liquide is a world leader in gases, technologies and services for industry and healthcare. Present in 72 countries with 67,800 employees, the Group serves more than 4 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the Group’s activities since its creation in 1902.
Taking action today while preparing the future is at the heart of Air Liquide’s strategy. With ADVANCE, its strategic plan for 2025, Air Liquide is targeting a global performance, combining financial and extra-financial dimensions. Positioned on new markets, the Group benefits from major assets such as its business model combining resilience and strength, its ability to innovate and its technological expertise. The Group develops solutions contributing to climate and the energy transition—particularly with hydrogen—and takes action to progress in areas of healthcare, digital and high technologies.
Air Liquide’s revenue amounted to more than 27.5 billion euros in 2023. Air Liquide is listed on the Euronext Paris stock exchange (compartment A) and belongs to the CAC 40, CAC 40 ESG, EURO STOXX 50, FTSE4Good and DJSI Europe indexes.
